Episode 240: Today, Ann unpacks Visa’s $2.4 billion acquisition of fraud intelligence company BioCatch as the payments giant looks to combat increasingly sophisticated cyberattacks and AI-powered scams. Then, we spin through market headlines, including reports of a pharmaceutical mega-merger between AstraZeneca and Bristol Myers Squibb, earnings from Tyson Foods and Nissan, and Boeing securing FAA clearance for its smallest 737 Max after years of delays. Finally, we dive into Weyerhaeuser – the 126-year-old timber company looking to double its profit with an AI-powered strategy.Visit Schwab.com/FinancialDecoderwww.brewmarkets.com Subscribe to the Brew Markets newsletter: https://www.morningbrew.com/brew-mark...Follow Brew Markets on social:Instagram: instagram.com/brewmarketsTikTok: tiktok.com/@brewmarketsX: x.com/brewmarketsFollow Ann Berry on social:Instagram: instagram.com/annberry_nycX: x.com/AnnBerry_NYCListen to Brew Markets Here: swap.fm/l/9Qk4z73Z2nEwFiCB4qeeWatch Brew Markets Here:⁠ https://www.youtube.com/@BrewMarketsStocks mentioned:$V $TSN $AZN $BMY $BA $WYThe content shared on this podcast is for informational and entertainment purposes only and should not be considered financial, legal, or investment advice. Brew Markets, Morning Brew and their hosts are not licensed financial advisors. Listeners should conduct their own research and consult with qualified professionals before making any financial decisions or investments. The views expressed are those of the hosts and guests and do not necessarily reflect the views of Morning Brew or its affiliates. This podcast may include paid endorsements or sponsorshipsLearn more about your ad choices. Visit megaphone.fm/adchoices